Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   

 

[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

Items 46 to 60 of 1026 total

per page
Page:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
Axon ID Name Description From price
2062 Alprostadil Prostaglandin EP (1-4) receptor antagonist €105.00
2948 AM 580 RAR-α agonist  Recently added €95.00
2971 Amcasertib First-in-class stemness kinase inhibitor €145.00
1738 AMD 3100 CXCR4 antagonist €85.00
1930 AMD 3465 hexahydrobromide Potent and selective CXCR4 antagonist €85.00
1916 AMG 208 Inhibitor of c-MET receptor tyrosine kinase (RTK) €110.00
2639 AMG 232 Potent, selective, and orally bioavailable MDM2-p53 inhibitor €115.00
1768 AMG 706 Multiple receptor tyrosine kinase inhibitor €105.00
2405 AMG 837 calcium salt Orally bioavailable partial agonist of GPR40 (FFA1) €110.00
1783 AMG 900 Aurora inhibitor (non-specific) €115.00
2863 AMI-1 Inhibitor of PRMT €99.00
1496 Aminobenzamide, 3- Competitive small molecule inhibitor of PARP €45.00
2368 Amuvatinib RTK inhibitor which effectively inhibits PDGFR, c-Kit and c-Met €105.00
2468 ANA 12 Selective TrkB antagonist with anxiolytic and antidepressant activity in mice €90.00
1490 Anacardic acid A HAT inhibitor €60.00

Items 46 to 60 of 1026 total

per page
Page:
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
Please wait...